Save time and get answers to complex questions with AI chat
Adefovir dipivoxil discount cardIs liver function monitoring necessary with lipitorEnhertu loss of exclusivity patent expirationOzempic jordan price 2026Nicardipine brand names
See the DrugPatentWatch profile for accutane
iPLEDGE is a mandatory risk management program for isotretinoin (Accutane and generics), required by the FDA to prevent fetal exposure due to the drug's severe birth defect risks. It applies to all patients, prescribers, pharmacies, and wholesalers. Everyone must register and comply monthly.[1]
Prescriptions halt until compliance. No grace periods—system locks after 7-day window. Treatment gaps over 1 month require restarting pregnancy tests. Non-compliance ends therapy.[1][2]
Other Questions About Accutane :